Precigen (PGEN) Non Operating Income (2012 - 2026)
Precigen (PGEN) reported Non Operating Income of $290000.0 for Q1 2026, up 4042.86% year-over-year from $7000.0 in Q1 2025, and down 99.79% quarter-over-quarter from $138.3 million in Q4 2025.
Precigen (PGEN) Non Operating Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Non Operating Income data on file, last reported at $290000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $290000.0, up 4042.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.9 million (up 473.05% YoY), and the FY2025 annual result was $43000.0, down 99.23% from the prior year.
- Non Operating Income declined to $290000.0 in Q1 2026 per PGEN's latest filing, from $138.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $138.3 million in Q4 2025 and troughed at -$111.9 million in Q3 2025.
- A 5-year average of $2.3 million and a median of $198000.0 in 2022 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 11818.6% in 2025 and fell as far as 3647.5% in 2025.
- A 5-year view of Non Operating Income shows it stood at $263000.0 in 2022, then jumped by 923.19% to $2.7 million in 2023, then jumped by 215.87% to $8.5 million in 2024, then jumped by 1527.51% to $138.3 million in 2025, then sank by 99.79% to $290000.0 in 2026.
- Business Quant data shows PGEN's Non Operating Income at $290000.0 in Q1 2026, $138.3 million in Q4 2025, and -$111.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 290,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 290,000.00 |
| Dec 31, 2025 | 138.34 Mn |
| Sep 30, 2025 | -111.86 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | 43,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 281,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 689,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | -942,000.00 |
| Jun 30, 2022 | -1.99 Mn |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | -18.59 Mn |
| Sep 30, 2021 | -133,000.00 |
| Jun 30, 2021 | -4.78 Mn |